1st Slemani Cancer Conference
4 February 2027 · World Cancer DayGrand Millennium Sulaimani, Slemani (Sulaimaniyah), Kurdistan Region – Iraq
Home › Scientific Tracks › Immunotherapy

Immunotherapy

Harnessing the immune system against cancer
DK
Track Chair
Prof. Daniel K. ChoNational Cancer Centre Singapore
ZO
Co-Chair
Dr. Zhilan OsmanHiwa Cancer Hospital, Slemani
About This Track

From checkpoint inhibitors to cellular therapy, this track covers the science and the practical management of immuno-oncology, including toxicity management and patient selection.

8+
Sessions
40+
Speakers
100+
Abstracts Expected
Topics Covered
  • Immune checkpoint inhibitors across tumour types
  • Biomarkers of response: PD-L1, TMB and beyond
  • Management of immune-related adverse events
  • CAR-T and cellular therapies
  • Combination strategies: IO + chemo / targeted / RT
  • Immunotherapy access and cost-effectiveness
Invited SpeakersView All Speakers →
Abstract Categories
  • Basic and Translational Research — Immunotherapy
  • Screening, Diagnosis and Imaging — Immunotherapy
  • Treatment and Clinical Outcomes — Immunotherapy
  • Supportive Care and Quality of Life — Immunotherapy
  • Case Reports and Clinical Observations — Immunotherapy
Learning Objectives
  • Select appropriate patients for immunotherapy
  • Recognise and manage immune-related adverse events
  • Understand emerging cellular therapy platforms
  • Apply combination strategies based on current evidence

Join leading experts in immunotherapy

Submit your abstract and be part of this global scientific exchange.

Submit Abstract →All Tracks